Piezo1 as a potential player in intracranial hemorrhage: From perspectives on biomechanics and hematoma metabolism
- PMID: 38808569
- PMCID: PMC11461532
- DOI: 10.7555/JBR.37.20230241
Piezo1 as a potential player in intracranial hemorrhage: From perspectives on biomechanics and hematoma metabolism
Abstract
Intracranial hemorrhage (ICH) causes numerous neurological deficits and deaths worldwide each year, leaving a significant health burden on the public. The pathophysiology of ICH is complicated and involves both primary and secondary injuries. Hematoma, as the primary pathology of ICH, undergoes metabolism and triggers biochemical and biomechanical alterations in the brain, leading to the secondary injury. Past endeavors mainly aimed at biochemical-initiated mechanisms for causing secondary injury, which have made limited progress in recent years, although ICH itself is also highly biomechanics-related. The discovery of the mechanically-activated cation channel Piezo1 provides a new avenue to further explore the mechanisms underlying the secondary injury. The current article reviews the structure and gating mechanisms of Piezo1, its roles in the physiology/pathophysiology of neurons, astrocytes, microglia, and bone-marrow-derived macrophages, and especially its roles in erythrocytic turnover and iron metabolism, revealing a potential interplay between the biomechanics and biochemistry of hematoma in ICH. Collectively, these advances provide deeper insights into the secondary injury of ICH and lay the foundations for future research.
Keywords: Piezo1; biomechanics; hematoma; intracranial hemorrhage; secondary injury.
Conflict of interest statement
The authors reported no conflict of interests.
Figures




Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Epidemiology of injuries: current trends and future challenges.Epidemiol Rev. 2000;22(1):112-9. doi: 10.1093/oxfordjournals.epirev.a018006. Epidemiol Rev. 2000. PMID: 10939015
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Interventions for eye movement disorders due to acquired brain injury.Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2. Cochrane Database Syst Rev. 2018. PMID: 29505103 Free PMC article.
Cited by
-
Mechanosensitive Piezo1 channel: an emerging target in demyelination disease.Front Cell Neurosci. 2025 Jul 9;19:1556892. doi: 10.3389/fncel.2025.1556892. eCollection 2025. Front Cell Neurosci. 2025. PMID: 40703567 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous